The functions of endothelial progenitor cells were significantly improved after treatment with intravenous immunoglobulin and aspirin in children with Kawasaki disease

Pediatric Cardiology

Volumn 32, Issue 4, 2011, Pages 455-460

  Xu, Ming Guo ^a   Men, Li Na ^a   Zu, Ying ^a   Zhao, Chun Yu ^a   Meng, Xiang Chun ^a   Wang, Tao ^a  

^a Shenzhen Children's Hospital   (China)

Author keywords

Endothelial progenitor cell; Intravenous immunoglobulin; Kawasaki disease

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; IMMUNOGLOBULIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ARTICLE; BLOOD LEVEL; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; DRUG DOSE REDUCTION; ENDOTHELIUM PROGENITOR CELL; FEMALE; HUMAN; HUMAN CELL; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; STEM CELL; THERAPY EFFECT;

ASPIRIN; CELLS, CULTURED; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFANT; MALE; MESENCHYMAL STEM CELLS; MUCOCUTANEOUS LYMPH NODE SYNDROME; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79953711990     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-011-9900-4     Document Type: Article

References (31)

1. Ahn SY, Jang GC, Shin JS, Shin KM, Kim DS (2003) Tumor necrosis factor-alpha levels and promoter polymorphism in patients with Kawasaki disease in Korea. Yonsei Med J 44(6):1021-1026 (Pubitemid 38081569)
2. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302):964-967 (Pubitemid 27087709)
3. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H et al (1999) VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. Embo J 18(14):3964-3972 (Pubitemid 29335849)
4. Brogan PA, Bose A, Burgner D, Shingadia D, Tulloh R, Michie C et al (2002) Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child 86(4):286-290 (Pubitemid 34289632)
5. Brogan PA, Shah V, Klein N, Dillon MJ (2004) Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury. Arthritis Rheum 50(2):589-597 (Pubitemid 38202231)
6. Burns JC, Glode MP (2004) Kawasaki syndrome. Lancet 364(9433):533-544 (Pubitemid 39070416)
7. Chen J, Huang L, Song M, Yu S, Gao P, Jing J (2009) C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells. J Cardiovasc Pharmacol 53(5):359-367
8. Fujii H, Li SH, Szmitko PE, Fedak PW, Verma S (2006) C-reactive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells. Arterioscler Thromb Vasc Biol 26(11):2476-2482 (Pubitemid 44607468)
9. Fukazawa R, Ogawa S (2009) Long-term prognosis of patients with Kawasaki disease: at risk for future atherosclerosis? J Nippon Med School 76(3):124-133
10. Furukawa S, Matsubara T, Ichiyama T (2008) Regulation of proinflammatory cytokine cascade in Kawasaki disease. Nippon Rinsho 66(2):258-264
11. He T, Smith LA, Harrington S, Nath KA, Caplice NM, Katusic ZS (2004) Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. Stroke 35(10):2378-2384 (Pubitemid 39311267)
12. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA et al (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348(7):593-600 (Pubitemid 36204953)
13. Hui-Yuen JS, Duong TT, Yeung RS (2006) TNF-alpha is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease. J Immunol 176(10):6294-6301
14. Kawasaki T (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 16(3):178-222
15. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H (1974) A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 54(3):271-276
16. Lau AC, Duong TT, Ito S, Wilson GJ, Yeung RS (2009) Inhibition of matrix metalloproteinase-9 activity improves coronary outcome in an animal model of Kawasaki disease. Clin Exp Immunol 157(2):300-309
17. Lau AC, Duong TT, Ito S, Yeung RS (2009) Intravenous immunoglobulin and salicylate differentially modulate pathogenic processes leading to vascular damage in a model of Kawasaki disease. Arthritis Rheum 60(7):2131-2141
18. Matsubara T, Furukawa S, Yabuta K (1990) Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. Clin Immunol Immunopathol 56(1):29-36 (Pubitemid 20220882)
19. Mitani Y, Sawada H, Hayakawa H, Aoki K, Ohashi H, Matsumura M et al (2005) Elevated levels of high-sensitivity C-reactive protein and serum amyloid A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease. Circulation 111(1):38-43 (Pubitemid 40070841)
20. Musunuru K, Kral BG, Blumenthal RS, Fuster V, Campbell CY, Gluckman TJ et al (2008) The use of high-sensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med 5(10):621-635
21. Nabata A, Kuroki M, Ueba H, Hashimoto S, Umemoto T, Wada H et al (2008) C-reactive protein induces endothelial cell apoptosis and matrix metalloproteinase-9 production in human mononuclear cells: implications for the destabilization of atherosclerotic plaque. Atherosclerosis 196(1):129-135
22. Niboshi A, Ozawa S, Hamaoka K (2008) Kawasaki disease and atherosclerosis. Nippon Rinsho 66(2):387-392
23. Pinna GS, Kafetzis DA, Tselkas OI, Skevaki CL (2008) Kawasaki disease: an overview. Curr Opin Infect Dis 21(3):263-270 (Pubitemid 351620381)
24. Tatara K, Kusakawa S, Itoh K, Kazuma N, Lee K, Hashimoto K et al (1989) Long-term prognosis of Kawasaki disease patients with coronary artery obstruction. Heart Vessels 5(1):47-51 (Pubitemid 19272716)
25. Terai M, Shulman ST (1997) Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr 131(6):888-893 (Pubitemid 28027615)
26. Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, Murayama T et al (2002) Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105(25):3017-3024 (Pubitemid 34693836)
27. Werner N, Junk S, Laufs U, Link A, Walenta K, Bohm M et al (2003) Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93(2):e17-e24
28. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A et al (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353(10):999-1007 (Pubitemid 41262334)
29. Xu MG, Wang JM, Chen L, Wang Y, Yang Z, Tao J (2009) Berberine-induced upregulation of circulating endothelial progenitor cells is related to nitric oxide production in healthy subjects. Cardiology 112(4):279-286
30. Xu MG, Men LN, Zhao CY, Zhao X, Wang YX, Meng XC et al (2010) The number and function of circulating endothelial progenitor cells in patients with Kawasaki disease. Eur J Pediatr 169(3):289-296
31. Zhang Y, Herbert BS, Rajashekhar G, Ingram DA, Yoder MC, Clauss M et al (2009) Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-alpha by way of the p38 mitogen-activated protein kinase pathway. Faseb J 23(5):1358-1365